Tuesday, May 24, 2022
News
NEWS HOME
COVISHIELD
 

Restricted emergency use approvals to Covishield, Covaxin not granted in haste: SC

New Delhi |Tuesday, 2022 3:45:10 AM IST
The Supreme Court on Monday said the material provided by the Centre does not warrant the conclusion that restricted emergency use approvals were granted to Covishield and Covaxin in haste, without thorough review of relevant data.... read..
 

COVID-19: India hands over Made in India Covishield vaccines to Cambodia

New Delhi | April 12, 2022 9:23:10 PM IST
India on Tuesday handed over to Cambodia 325,000 doses of Made in India Covishield vaccines under the Quad Vaccine Partnership scheme.... read..
 

Slashed COVID-19 vaccine Covishield's prices to ensure more accessibility, reach, says SII's Adar Poonawalla

By Shalini Bhardwaj

New Delhi | April 12, 2022 7:52:18 PM IST
The decision to slash the prices of the precautionary dose of the COVID-19 vaccine Covishield, which is now available for all adults, was taken to make it more affordable, accessible and within reach of the masses, Chief Executive Officer (CEO) of Serum I... read..
 

COVID vaccine: Covishield's price reduced from Rs 600 to Rs 225 per dose at pvt hospitals

Pune (Maharashtra) | April 9, 2022 6:25:35 PM IST
Pune-based Serum Institute of India (SII) on Saturday announced that it has revised the price of its COVID vaccine Covishield for private hospitals from Rs 600 to Rs 225 per dose."We are pleased to announce that after discussion with the Central Governmen... read..
 

DCGI grants conditional market approval for Covaxin, Covishield

New Delhi | January 27, 2022 10:51:21 PM IST
The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin and Covishield for restricted use in emergency situations in the adult population.... read..
 

Covaxin, Covishield given normal new drug permission in adult population with conditions: Health Minister

New Delhi | January 27, 2022 7:20:50 PM IST
Union Health Minister Dr Mansukh Mandaviya on Thursday said that the Central Drugs Standard Control Organisation (CDSCO) has now upgraded the permission for Covaxin and Covishield from restricted use in emergency situations to normal new drug permission i... read..
 

DGCI grants conditional market approval for Covaxin, Covishield

New Delhi | January 27, 2022 5:20:56 PM IST
The Drugs Controller General of India (DCGI) on Thursday granted conditional regular market approval for COVID-19 vaccines Covaxin and Covishield for restricted use in emergency situations in the adult population.... read..
 

Regular market approval to Covishield, Covaxin expected soon after final price fixation: Sources

By Shalini Bhardwaj

New Delhi | January 26, 2022 7:20:11 PM IST
The regular market approval from Drugs Controller General of India (DCGI) to COVID-19 vaccine Covishield and Covaxin is expected soon, but only after price fixation which is still underway, official sources told ANI on Wednesday.... read..
 

Covishield, Covaxin cleared for regular market approval

New Delhi |Thursday, 2022 5:15:07 AM IST
India's two main vaccines -- Bharat Biotechs Covaxin and Serum Institute of India's Covishield -- on Wednesday got the nod for regular market authorisation.... read..
 

SEC recommends regular market approval to Covaxin, Covishield for adults

By Shalini Bhardwaj

New Delhi | January 19, 2022 11:20:58 PM IST
The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines Covaxin and Covishield with conditions for the adult popul... read..
 

SEC asks for more data to grant full market approval to Covaxin and Covishield

New Delhi | January 14, 2022 11:20:29 PM IST
The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, sources tol... read..
 

Jharkhand man paralysed for four years says he is able to move and speak after taking Covishield vaccine

Bokaro (Jharkhand) | January 14, 2022 10:20:18 PM IST
A 55-year-old man, who had become paralysed and lost his voice four years ago in an accident, said he was able to move and speak after he was given Covishield vaccine on January 4.... read..
 

DCGI's SEC to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today: Sources

By Shalini Bhardwaj

New Delhi | January 14, 2022 12:50:28 PM IST
Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said.... read..
 

Serum Institute applies for full market authorisation of Covishield

New Delhi |Friday, 2021 9:15:08 PM IST
Pune-based Covid vaccines manufacturer Serum Institute has requested the Indian health ministry and Central Drugs Standard Control Organisation (CDSCO) for full market authorisation for its Covishield vaccine.... read..
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
TN launches All Village Integrated Devel...
J-K: Govt replaces Sheikh Abdullah's ima...
Vinai Kumar Saxena appointed as new L-G ...
Construction of Ram Mandir in Ayodhya is...
Youth Cong starts 'India Rising Talent' ...
HC notice on PIL claiming over 45K teach...
More...    
 
 Top Stories
Pernod Ricard India announces the r... 
New Business Success Book By Abhish... 
Binomo is official sponsor for Sunr... 
Tiger Logistics aims to modernise s... 
Buy Mi TV on Bajaj Finserv EMI Stor... 
Kahi Unkahi celebrated life and lit... 
PM Modi to visit Hyderabad and Chen... 
Ajay Devgn's daughter Nysa looks st...